How is BindCraft, the automated pipeline for de novo protein binder design, changing the protein design industry? Martin Pacesa, assistant professor of pharmacology at the University of Zurich, joins The Chain to discuss how BindCraft is helping non-protein designers learn how to design proteins—and how the role of the protein designer will evolve. With host Chris Bahl, their conversation explores how BindCraft may help with drug development, its role in the democratization of tools and resources, and how to work more collaboratively with AI models. Pacesa will also be speaking at May’s PEGS Summit in Boston.  

Links from this episode:  

AI Proteins 

UZH - Institute of Pharmacology and Toxicology  

University of Zurich 

Models & Molecules Podcast

 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Cambridge Healthtech Institute. Innehållet i podden är skapat av Cambridge Healthtech Institute och inte av, eller tillsammans med, Poddtoppen.